4.85
1.02%
-0.05
Vorhandelsmarkt:
5.09
0.24
+4.95%
Schlusskurs vom Vortag:
$4.90
Offen:
$4.97
24-Stunden-Volumen:
486.03K
Relative Volume:
3.68
Marktkapitalisierung:
$222.31M
Einnahmen:
$31.99M
Nettoeinkommen (Verlust:
$-11.97M
KGV:
-19.40
EPS:
-0.25
Netto-Cashflow:
$-1.75M
1W Leistung:
+13.85%
1M Leistung:
+21.25%
6M Leistung:
+116.52%
1J Leistung:
+127.17%
Koru Medical Systems Inc Stock (KRMD) Company Profile
Firmenname
Koru Medical Systems Inc
Sektor
Telefon
845-469-2042
Adresse
100 CORPORATE DRIVE, MAHWAH, NY
Vergleichen Sie KRMD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
KRMD
Koru Medical Systems Inc
|
4.85 | 222.31M | 31.99M | -11.97M | -1.75M | -0.25 |
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Koru Medical Systems Inc Stock (KRMD) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
2023-09-07 | Eingeleitet | B. Riley Securities | Buy |
2023-09-07 | Eingeleitet | Lake Street | Buy |
2022-11-10 | Hochstufung | Canaccord Genuity | Hold → Buy |
2022-11-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
2021-01-26 | Herabstufung | Canaccord Genuity | Buy → Hold |
2021-01-26 | Herabstufung | Piper Sandler | Overweight → Neutral |
2020-08-10 | Eingeleitet | H.C. Wainwright | Buy |
2020-07-16 | Eingeleitet | Canaccord Genuity | Buy |
2020-06-24 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Koru Medical Systems Inc Aktie (KRMD) Neueste Nachrichten
Revolutionary SCIg Therapy Innovation: KORU Medical and SCHOTT Join Forces to Transform Home Infusion - StockTitan
KORU Medical Systems Inc (KRMD)’s highs and lows: A closer look at its stock price fluctuations - US Post News
KRMD’s Market Whiplash: 19.48% YTD Rise, 18.40% Rise in 30 Days - The InvestChronicle
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology - Marketscreener.com
KORU Medical partners for Phase III trial in rare kidney disorder - Investing.com Canada
Major Breakthrough: KORU Medical Targets 30,000 Patient Market with Revolutionary Kidney Treatment Trial - StockTitan
KORU Medical Systems Inc. (KRMD) is a Great Momentum Stock: Should You Buy? - MSN
Albion Financial Group UT Has $2.18 Million Stock Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD) - MarketBeat
KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $6.00 - Defense World
KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Update - MarketBeat
Craig Hallum Raises KORU Medical Systems (NASDAQ:KRMD) Price Target to $6.00 - MarketBeat
Koru Medical stock price target raised, buy rating on strong period - Investing.com Australia
Analyst Expectations For KORU Medical Systems's Future - Benzinga
Koru Medical stock price target raised, buy rating on strong period By Investing.com - Investing.com South Africa
What is B. Riley’s Estimate for KRMD FY2024 Earnings? - Defense World
B. Riley Has Positive Estimate for KRMD FY2024 Earnings - MarketBeat
Jane Street Group LLC Sells 52,614 Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) - Defense World
KORU Medical Systems (NASDAQ: KRMD) Issues Press Release on Preliminary Financial Results - Defense World
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter - Yahoo Finance
KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $5.00 - MarketBeat
Canaccord maintains Buy on Koru Medical seeing positive cash flow for q4/24 - Investing.com Australia
KORU Medical Systems, Inc. Announces Preliminary Unaudited Revenues Guidance for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
KORU Medical Reports Record Q4: Revenue Surges 23% to $8.9M with Positive Cash Flow - StockTitan
Reviewing KORU Medical Systems (NASDAQ:KRMD) and INVO Bioscience (NASDAQ:INVO) - Defense World
Geode Capital Management LLC Purchases 28,323 Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) - Defense World
Promising US Penny Stocks To Watch In January 2025 - Simply Wall St
Ambulatory Infusion Pumps Market Future Business - openPR
Koru Suit Says Ex-CEO’s Insider Info Built Rival’s Infusion Tech - Bloomberg Law
KORU Medical Systems (NASDAQ:KRMD) and Cytosorbents (NASDAQ:CTSO) Head-To-Head Comparison - Defense World
KORU Medical Systems, Inc. (NASDAQ:KRMD) Stock Position Decreased by RBF Capital LLC - MarketBeat
US Penny Stocks To Watch In December 2024 - Simply Wall St
Repro Med Systems stock hits 52-week high at $4.05 By Investing.com - Investing.com Nigeria
Repro Med Systems stock hits 52-week high at $4.05 - Investing.com India
KORU Medical Systems to Present at Piper Sandler's Healthcare Conference | KRMD Stock News - StockTitan
KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference - Business Wire
KORU Medical Systems Announces Financial Results for Fiscal Quarter Ended September 30, 2024 - Defense World
KORU Medical Systems, Inc. (NASDAQ:KRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.10 - Simply Wall St
KORU Medical Systems Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2024 Earnings Call Transcript - Insider Monkey
Koru Medical price target raised to $4 from $3 at Canaccord - Yahoo Finance
Koru Medical Systems stock target increased, holds buy on strong quarter - Investing.com India
KRMD (KORU Medical Systems) Total Stockholders Equity : $18.71 Mil (As of Jun. 2024) - GuruFocus.com
Koru Medical stock price target upgraded, rating held on Q3 report - Investing.com
KORU Medical Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $4.00 at Canaccord Genuity Group - MarketBeat
Finanzdaten der Koru Medical Systems Inc-Aktie (KRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):